GHSI — Guardion Health Sciences Income Statement
0.000.00%
Last trade - 00:00
- $12.75m
- $7.14m
- $12.25m
- 33
- 32
- 100
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.903 | 1.89 | 7.23 | 11 | 12.2 |
Cost of Revenue | |||||
Gross Profit | 0.562 | 0.559 | 3.11 | 4.52 | 5.39 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 11.4 | 10.4 | 32 | 28.5 | 16.5 |
Operating Profit | -10.5 | -8.55 | -24.7 | -17.4 | -4.21 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.9 | -8.57 | -24.7 | -14.9 | 0.158 |
Net Income After Taxes | -10.9 | -8.57 | -24.7 | -14.9 | 0.158 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.9 | -8.57 | -24.7 | -14.9 | 0.158 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.9 | -8.57 | -24.7 | -15.9 | 0.158 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -76.6 | -29.9 | -22.1 | -5.14 | 0.333 |